* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Notification: “Statement of activity with biological agents
Epigenomics wikipedia , lookup
Synthetic biology wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Non-coding DNA wikipedia , lookup
DNA vaccination wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Genome editing wikipedia , lookup
Microevolution wikipedia , lookup
Genomic library wikipedia , lookup
Helitron (biology) wikipedia , lookup
Molecular cloning wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genetically modified food wikipedia , lookup
Designer baby wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Genetic engineering wikipedia , lookup
Genetically modified organism containment and escape wikipedia , lookup
Notification of exempt activities Biosafety Committee Registration No. _____ To be filled in by CBS STATEMENT OF ACTIVITY WITH BIOLOGICAL AGENTS AND CHEMICAL EXEMPT FROM LIABILITY OF CBS AUTHORIZATION IMPORTANT: Please fill in this application form if you consider that your activity with biological agents fulfills some exemption condition of the statement to the Biosafety Committee as defined in paragraph 9 (see below). 1. Principal investigator: 2. Department/Unit/Facility: 3. Centre: 4. Phone no.: E-mail address: 5. Title of the experimental procedure: 6. Center / facility where the activity will 7. Activity purpose (to be achieved): 8. Brief description of the agent/s (enclose product safety sheet): Brief summary of the experimental procedure to be performed: 9. Conditions for exemption (mark all that apply): A Activities with biological agents, no GMOs, of biosafety level I, pure cultures of bacteria, viruses, fungi, protozoa, collection cell lines (CECT, ATCC, DSMZ, etc.), non-primate primary cell lines, certified pathogen free cell lines,... B Working with synthetic molecules of recombinant DNA that cannot be multiplied in any organism or biological system. C The storage, purchasing, shipping, culture, transport, destruction, disposal or use of commercial GMOs, as long as the conditions of use will be conformed to the conditions of commercialization authorization established by the competent authority (e.g. genetically modified seeds, medicines, genetically modified animals, etc.). D E F G The transport of biological agents by road, rail, sea, river or air. (The transport of these agents will be done according the “Guide on regulation for the Transport of infectious substances 2007-2008”. World Health Organization). Working with biotoxins with an LD50 in vertebrates of more than 100 micrograms per kg of body weight. Those chemical products in which the risk is either well identified or do not have a high danger. Experimental procedures with established lines of genetically modified mice of P1 risk level, provided that they are not inoculated with biological agents, viral vectors or hazardous chemical agents. Note: once filled in and signed, this application form will be sent to [email protected] Update 09/16 1 Notification of exempt activities Biosafety Committee Registration No. _____ To be filled in by CBS Procedures do require a notification for authorization, if: - The experiment involves the cloning of known oncogenes, total DNA or more than half of the genome of biological agents from biosafely level 3 or 4. - Cloning experiments in animal, human or plant pathogens (from biosafety level 2 or higher). - The experiment is performed in large scale (more than 50 liters of culture). - There is a deliberate transfer of an antibiotic-resistant gene in a microorganism that is not naturally resistant, or if this incorporation could result dangerous for its use in medicine, veterinary or agriculture. - Recombinant DNA containing coding genes for the biosynthesis of a toxin against vertebrates with an LD50 of less than 100ng/kg of body weight. - Deliberate transfer of recombinant DNA in humans, animals or plants (e.g. gene therapy experiments). - Working with more than 2/3 parts of genomes of viral vectors infecting plants, animals or their defective products in presence of an auxiliary virus. The undersigned, being the principal investigator of the procedure, declares that all information stated in this application form is complete and true. He/She also declares that he/she will apply the necessary biosafety measures and practices in accordance with legal regulations concerning the protection of humans and the environment (Law 31/1995, RD 664/97, Law 9/2003 and RD 178/2004), and any significant change in the work conditions in which this research procedure will be developed, will be communicated to the Biosafety Committee beforehand. Date: Signature of the principal investigator who stated the declaration Note: once filled in and signed, this application form will be sent to [email protected] Update 09/16 2